Polen Capital acquired 580k Boston Scientific shares worth $28M. That's 0.18% of their equity portfolio (31st largest holding). Polen Capital started to build up the position in Boston Scientific in Q3 2025. Since then they sold 5.02M shares. The investor's estimated purchase price is $60.1M, resulting in a loss of 53%.
Diamond Hill Capital Management Inc. decreased its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 2.8% in the second quarter, accord...
OLD Dominion Capital Management Inc. boosted its holdings in shares of Boston Scientific Co. (NYSE:BSX) by 1.2% in the third quarter, according to its most r...
Blackstone Minerals Limited (ASX code: BSX) is pleased to announce it has received firm commitments from sophisticated, professional and institutional invest...